Cargando…
Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment
Autores principales: | Girardin, François R., Cohen, Karen, Schwenkglenks, Matthias, Durand-Zaleski, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229043/ https://www.ncbi.nlm.nih.gov/pubmed/37261286 http://dx.doi.org/10.3389/fphar.2023.1210002 |
Ejemplares similares
-
Grand Challenges in Pharmacoeconomics and Health Outcomes
por: Dubois, Dominique J.
Publicado: (2010) -
Pharmacoeconomic studies in Nepal: the need of the hour
por: Acharya, Mahip
Publicado: (2014) -
Light at the end of the tunnel?: The Great Indian Pharmacoeconomics story
por: Thakkar, Karan B., et al.
Publicado: (2013) -
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review
por: Huang, Hui-Yao, et al.
Publicado: (2020) -
How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea
por: Bae, SeungJin, et al.
Publicado: (2022)